26.3% Below Target

The consensus Wall Street price target for BX is $156.29, representing 26.3% upside from the current price of $123.775. With 29 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

BX has a consensus rating of "Buy" based on 29 Wall Street analysts. The rating breakdown is predominantly bullish, with 18 Buy/Strong Buy ratings. The consensus 12-month price target of $156.29 implies 26.3% upside from current levels.

BX trades at a forward P/E of 21.0201x, representing a moderate valuation. With analysts targeting $156.29 (26.3% implied move), the stock appears reasonably valued with upside.

The most bullish Wall Street analyst has a price target of $184 for BX, while the most conservative target is $130. The consensus of $156.29 represents the median expectation. Our quantitative valuation model projects a bull case target of $274 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

BX is heavily covered by Wall Street, with 29 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 18 have Buy ratings, 10 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month BX stock forecast based on 29 Wall Street analysts shows a consensus price target of $156.29, with estimates ranging from $130 (bear case) to $184 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $208, with bear/bull scenarios of $131/$274.

Our quantitative valuation model calculates BX's fair value at $208 (base case), with a bear case of $131 and bull case of $274. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.

BX trades at a forward P/E ratio of 21.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 31.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on BX, with a "Buy" consensus rating and $156.29 price target (26.3% upside). 18 of 29 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

BX analyst price targets range from $130 to $184, a 35% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $156.29 consensus represents the middle ground. Our model's $131-$274 range provides an independent fundamental perspective.